@richardursomd NO. It works for phase one symptoms, by preventing the virus binding to hemoglobin, preventing all h…
NO. It works for phase one symptoms, by preventing the virus binding to hemoglobin, preventing all hypoxemic cell death.
It still leaves a person vulnerable to phase 2 sudden death, from autoimmune venous epithelial cell destruction and subsequent blood clots.
Ivermectin.
— Adam Gaertner (@veryvirology) May 28, 2020